Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoFIRST: Ultrasound-induced Blood Brain Barrier Opening in Newly Diagnosed Glioblastoma
NCT04614493Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2021
- Primary completion
- Mar 2024
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial in glioblastoma (GBM) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Progression Free Survival up to 18 months. Status: unknown.
02
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04614493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04614493.